Blog
RSS FeedPosted by Michael Wonder on 03 Feb 2023
Improved access to PBS medicines for pulmonary arterial hypertension
3 February 2023 - Access to pulmonary arterial hypertension PBS medicines has further improved as an outcome of the post-market review ...
Posted by Michael Wonder on 01 Feb 2023
New Parkinson's disease treatment added to PBS
1 February 2023 - From 1 February, Australians with Parkinson’s disease will have access to a new medicine on the PBS. ...
Posted by Michael Wonder on 31 Jan 2023
Schedule of Pharmaceutical Benefits - 1 February 2023
1 February 2023 - The February 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jan 2023
Call for Enhertu to be registered on Pharmaceutical Benefits Scheme
31 January 2023 - Sarah Lee has been forced to use her super and life insurance to pay for the treatment. ...
Posted by Michael Wonder on 23 Jan 2023
Mum's push for cystic fibrosis treatment to be subsidised for children under 12
23 January 2023 - Mila was diagnosed with cystic fibrosis aged just one, after experiencing lung failure in hospital, and ...
Posted by Michael Wonder on 03 Jan 2023
Schedule of Pharmaceutical Benefits - 1 January 2023
1 January 2023 - The January 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 07 Dec 2022
Updated eligibility for COVID-19 oral treatment
7 December 2022 - COVID-19 treatments can be taken in your own home and can help reduce your symptoms. ...
Posted by Michael Wonder on 03 Dec 2022
Hopes $55k breast cancer drug Keytruda will get PBS listing
3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...
Posted by Michael Wonder on 30 Nov 2022
Schedule of Pharmaceutical Benefits - 1 December 2022
1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 27 Nov 2022
Cheaper medicines for high cholesterol and chronic heart failure
28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell ...
Posted by Michael Wonder on 27 Nov 2022
Cost of life-saving heart disease drugs slashed, saving patients thousands
27 November 2022 - Life-saving medicines that tackle Australia's biggest killer are about to be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 17 Nov 2022
New COVID-19 vaccines for eligible Australians
15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...
Posted by Michael Wonder on 01 Nov 2022
First immunotherapy for patients with a potentially life threatening type of non-melanoma skin cancer now available on the PBS
1 November 2022 - Australians with a potentially life-threatening type of non-melanoma skin cancer will for the first time, have ...
Posted by Michael Wonder on 01 Nov 2022
Schedule of Pharmaceutical Benefits - 1 November 2022
1 November 2022 - The November 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Oct 2022
Expanded access to COVID-19 oral antiviral treatments on the PBS
1 November 2022 - Expanded eligibility criteria for COVID-19 oral anti-viral treatments (Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir) ...